Stock Movers BioMarin Rises, FedEx Drops and Nike Sinks on Sales Warning
Dec 19, 2025
BioMarin is on the rise after announcing its $4.8 billion acquisition of Amicus Therapeutics, expanding its portfolio for rare diseases. Meanwhile, FedEx shares plummet due to cost pressures and a significant earnings impact from grounding its MD-11 planes. Nike faces challenges as it predicts a sales decline amid struggles in China and with its Converse brand, prompting a targeted price cut from analysts. The market reflects mixed reactions, highlighting the volatile landscape of these major companies.
AI Snips
Chapters
Transcript
Episode notes
Nike Sales Warning And Margin Pressure
- Nike warned third-quarter sales will fall in the low single digits, driven by weakness in China and its Converse brand.
- Gross margins will shrink about two percentage points partly due to tariffs, surprising investors after recent growth.
Hosts Compare Sneaker Trends
- Paul Sweeney and Scarlet Fu traded personal views about Converse's street presence and sneaker trends as context for Nike's weak brand performance.
- They referenced high-school fashion shifts and competing sneaker styles to illustrate Converse's slump.
FedEx Faces Grounding Costs Despite Upgrades
- FedEx upgraded full-year targets but the beat was smaller than Q2 and shares still fell on cost headwinds.
- The company expects a $600 million hit to adjusted earnings from grounding some cargo jets, weighing on the turnaround.